| November 28, 2012 |
| Mimetogen Pharmaceuticals Inc. Announces Issuance of Key US Patent Protecting the Use of MIM-D3 to Treat Dry Eye Disease |
|
|
|
| January 05, 2012 |
| Mimetogen Pharmaceuticals Inc. Appoints Kim Brazzell, Ph.D. as Chief Medical Officer |
|
|
|
| June 26, 2011 |
| Mimetogen Pharmaceuticals Inc. Announces Positive Top Line Data from Phase II Clinical Trial of MIM-D3 for Dry Eye Disease |
|
|
